As a drug that may inhibit the COVID_19,cepharanthine is the main active ingredient extracted from Stephania,a traditional Chinese medicine.Chinese patent medicine has been listed in China and abroad for more than 40 years.
On May 10,2022,Chinese scientists discovered a treatment for covid_ 19 new drugs that have obtained national invention patents.The patent specification shows that 10μM(micromol/L)cepharanthine inhibits coronavirus replication by 15393 times.
As soon as this information came out,it was very exciting before the COVID 19 had not been solved effectively.Although cepharanthine is still in the drug research and development stage and has not been officially applied in clinical practice,it is also very good news for the current wanton situation of the Covid 19.Moreover,according to media reports,some American scholars have previously published papers in science and confirmed that the research data of cepharanthine is better than paxlovid,which has been approved for listing.At present,a Canadian pharmaceutical enterprise has contacted with the US FDA to carry out a clinical trial study on the treatment of COVID-19 with Cepharanthine.It is hoped that there will be better progress in the R&D and clinical utilization of this drug in the near future.
Cepharanthine(CEP)is a naturally occurring alkaloid derived from Stephania cepharantha Hayata and demonstrated to have unique anti-inflammatory,antioxidative,immunomodulating,antiparasitic,and antiviral properties.
Its therapeutic potential as an antiviral agent has never been more important than in combating COVID-19 caused by severe acute respiratory syndrome coronavirus type 2(SARS-CoV-2)virus.
Among the few patent owners,we have patents related to Cepharanthine.
Yunnan Hande Bio-tech Co.,Ltd.is a manufacturer and supplier with 28+experience in high concentration extraction and separation of plants.We patented the extraction method of Cepharanthine as early as August 2011.Our patent describes in detail how stephanine is extracted.If you need Cepharanthine in this regard,don’t hesitate,please contact us immediately.
Post time: May-16-2022